Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Treadwell Therapeutics

Request full access

Developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including aneuploidy and immunogenicity

New York City, United StatesFounded 2020Biotech & Life Sciences

About Treadwell Therapeutics

Treadwell Therapeutics is a clinical-stage oncology company that operates in the healthcare sector, specifically in the field of cancer treatment. The company is dedicated to developing innovative therapies for cancer, focusing on novel targets that have not been extensively explored in the past. Treadwell serves a market of patients who have limited treatment options, aiming to provide them with new, potentially life-changing solutions.

The company operates on a business model that involves the complete drug discovery and development process, all under one roof. This means that Treadwell is involved in every step of the process, from the initial concept and scientific research to the clinical trials and beyond. This approach allows the company to maintain control over the quality and direction of its research and development, potentially leading to more effective and innovative treatments.

Treadwell's revenue is generated primarily through the development and commercialization of its therapies. As the company advances its clinical candidates and brings them to market, it stands to earn income from the sales of these treatments. Additionally, the company may also generate revenue through partnerships with other healthcare companies or through grants and funding for its research.

In summary, Treadwell Therapeutics is a pioneering oncology company that aims to break new ground in cancer treatment. It serves a market of patients with limited options, using its in-house drug discovery and development engine to create innovative therapies.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
New York City, United States
Employees
11
Open positions
None listed
Dealroom signal
64.8/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B
Investment activity
1 company, latest Oct 2021
Capital deployed
—
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2021 $91M $364M 3W Fund Management · Sino Biopharmaceutical · Adrian Cheng · Alpha Win Capital ↗
SPINOUTOther financing Mar 2020 $0 — University Health Network —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Treadwell Therapeutics website traffic

Latest recorded traffic for Treadwell Therapeutics is 2.1K monthly website visits, up 23.5% over the last three months. Treadwell Therapeutics's team declined 21.4% over the past year.

Latest monthly visits2.1K 3-month web change+23.5% 1-year team growth-21.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Treadwell Therapeutics in the New York City ecosystem

Live from Dealroom

The Treadwell Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Sino Biopharmaceutical
  • 3W Fund Management
  • Adrian Cheng
  • Alpha Win Capital
  • TIO Bioventures
  • Prosperous Alliance Investments

Other known investors1 additional known investor

  • University Health Network
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇦 Canada50%
🇺🇸 United States40%
🇭🇰 Hong Kong10%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Treadwell Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Treadwell Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.